AMAG
AMAG Pharmaceuticals, Inc.
AMAG
AMAG
Delisted
AMAG was delisted on the 13th of November, 2020.
170 hedge funds and large institutions have $803M invested in AMAG Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 62 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
–
Holders Change %
0%
% of All Funds
3.9%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
29
Increased
53
Reduced
62
Closed
28
Calls
$5.55M
Puts
$14.8M
Net Calls
-$9.29M
Net Calls Change
-$4.72M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$38.4M |
| 2 |
Renaissance Technologies
New York
|
+$14M |
| 3 |
BC
Broadfin Capital
New York
|
+$12.1M |
| 4 |
CEI
Clark Estates Inc
New York
|
+$4.94M |
| 5 |
JPMorgan Chase & Co
New York
|
+$4.88M |
Top Sellers
| 1 |
LSV Asset Management
Chicago,
Illinois
|
-$14.8M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$8.4M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$7.35M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.35M |
